MAP — Microba Life Sciences Balance Sheet
0.000.00%
- AU$72.78m
- AU$46.10m
- AU$5.42m
- 14
- 24
- 46
- 16
Annual balance sheet for Microba Life Sciences, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 11 | 6.9 | 13 | 26.4 | 31.1 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.162 | 0.623 | 1.65 | 3.42 | 7.24 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 11.5 | 8.11 | 16.2 | 35.8 | 41.5 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.6 | 1.63 | 1.2 | 2.81 | 2.58 |
Net Intangible Assets | |||||
Total Assets | 14 | 10.8 | 18.5 | 39.5 | 47 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.15 | 2.84 | 3.35 | 5.26 | 7.82 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 1.43 | 3.1 | 3.55 | 5.94 | 8.38 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 12.6 | 7.7 | 14.9 | 33.5 | 38.6 |
Total Liabilities & Shareholders' Equity | 14 | 10.8 | 18.5 | 39.5 | 47 |
Total Common Shares Outstanding |